Botulinum neurotoxin;La neurotoxine botulinique

Revue Neurologique

Volumn 166, Issue 1, 2010, Pages 7-20

  Poulain, B ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Botulinum toxin; Central nervous system; Dissemination; Myorelaxing action; Neuromuscular junction

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BOTULINUM TOXIN;

ACETYLCHOLINE RELEASE; CHOLINERGIC TRANSMISSION; ENZYME INHIBITION; HUMAN; MUSCLE ATROPHY; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; PARALYSIS; REVIEW; TOXICOKINETICS;

ANIMALS; BOTULINUM TOXINS; CENTRAL NERVOUS SYSTEM; CYTOSOL; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNIZATION; NEURONS; NEUROTOXINS; PEPTIDE HYDROLASES; PERIPHERAL NERVOUS SYSTEM; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION;

EID: 76349088984     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.09.004     Document Type: Review

References (121)

1. M.A. Al-Muharraqi, Z. Fedorowicz, J. Al Bareeq, R. Al Bareeq, and M. Nasser Botulinum toxin for masseter hypertrophy Cochrane Database Syst Rev 1 2009 CD007510
2. F.H. Al-Saleem, D.M. Ancharski, E. Ravichandran, S.G. Joshi, A.K. Singh, Y. Gong, et al. The role of systemic handling in the pathophysiologic actions of botulinum toxin J Pharmacol Exp Ther 326 2008 856 863
3. F. Antonucci, C. Rossi, L. Gianfranceschi, O. Rossetto, and M. Caleo Long-distance retrograde effects of botulinum neurotoxin A J Neurosci 28 2008 3689 3696
4. J.W. Arndt, M.J. Jacobson, E.E. Abola, C.M. Forsyth, W.H. Tepp, J.D. Marks, et al. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4 J Mol Biol 362 2006 733 742
5. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher the Working Group on Civilian Biodefense Botulinum toxin as a biological weapon: medical and public health management J Am Med Assoc 285 2001 1059 1070 (Pubitemid 32176420)
6. M.Z. Atassi Basic immunological aspects of botulinum toxin therapy Mov Disord 19 Suppl. 8 2004 S68 84
7. H. Bigalke Properties of pharmaceutical products of botulinum neurotoxins J. Jankovic A. Albanese M.Z. Atassi J.O. Dolly M. Hallett N.H. Mayer, editors. Botulinum toxin - Therapeutic clinical practice and science 2009 Saunders Elsevier 389 397
8. C.R. Billante, D.L. Zealear, M. Billante, J.H. Reyes, G. Sant'Anna, and R. Rodriguez Comparison of neuromuscular blockade and recovery with botulinum toxins A and F Muscle Nerve 26 2002 395 403 (Pubitemid 34977019)
9. T. Binz, and A. Rummel Cell entry strategy of clostridial neurotoxins J Neurochem 109 2009 1584 1595
10. J. Blasi, E.R. Chapman, E. Link, T. Binz, S. Yamasaki, and P. De Camilli Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 Nature 365 1993 160 163 (Pubitemid 23282061)
11. J. Blümel, J. Frevert, and A. Schwaier Comparative antigenicity of employees of Merz Pharmaceuticals which sponsored all the three preparations of botulinum neurotoxin type A in the rabbit Neurotox Res 9 2006 238
12. G.E. Borodic, and R. Ferrante Effects of repeated botulinum toxin injections on orbicularis oculi muscle J Clin Neuroophthalmol 12 1992 121 127
13. M.A. Breidenbach, and A.T. Brunger Substrate recognition strategy for botulinum neurotoxin serotype A Nature 432 2004 925 929 (Pubitemid 40037157)
14. A.S.V. Burgen, F. Dickens, and L.T. Zatman The action of botulinum toxin on the neuromuscular junction J Physiol (Lond) 109 1949 10 24
15. M. Caleo, F. Antonucci, L. Restani, and R. Mazzocchio A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism? J Neurochem 109 2009 15 24
16. M. Caleo, and G. Schiavo Central effects of tetanus and botulinum neurotoxins Toxicon 54 2009 593 599
17. Q. Chai, J.W. Arndt, M. Dong, W.H. Tepp, E.A. Johnson, and E.R. Chapman Structural basis of cell surface receptor recognition by botulinum neurotoxin B Nature 444 2006 1096 1100 (Pubitemid 46018532)
18. F. Chen, G.M. Kuziemko, and R.C. Stevens Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species Infect Immun 66 1998 2420 2425 (Pubitemid 28261733)
19. D.K. Chhetri, J.H. Blumin, H.V. Vinters, and G.S. Berke Histology of nerves and muscles in adductor spasmodic dysphonia Ann Otol Rhinol Laryngol 112 2003 334 341
20. S.H. Cliff, H. Judodihardjo, and E. Eltringham Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study J Cosmet Dermatol 7 2008 50 54 (Pubitemid 351228167)
21. A. Couesnon, Y. Pereira, and M.R. Popoff Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers Cell Microbiol 10 2008 375 387
22. A. Curra, C. Trompetto, G. Abbruzzese, and A. Berardelli Central effects of botulinum toxin type A: evidence and supposition Mov Disord 19 Suppl 8 2004 S60 S64
23. B.R. DasGupta, D.A. Boroff, and E. Rothstein Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A Biochem Biophys Res Commun 22 1966 750 756
24. A. de Paiva, F. Meunier, J. Molgó, K.R. Aoki, and J.O. Dolly Functional repair of motor endpates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci U S A 96 1999 3200 3205 (Pubitemid 29148868)
25. B.Z. Dolimbek, K.R. Aoki, L.E. Steward, J. Jankovic, and M.Z. Atassi Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A Mol Immunol 44 2007 1029 1041 (Pubitemid 44414991)
26. J.O. Dolly, J. Black, R.S. Williams, and J. Melling Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization Nature 307 1984 457 460 (Pubitemid 14132060)
27. M. Dong, F. Yeh, W.H. Tepp, C. Dean, E.A. Johnson, R. Janz, et al. SV2 is the protein receptor for botulinum neurotoxin A Science 312 2006 592 596
28. M. Dong, H. Liu, W.H. Tepp, E.A. Johnson, R. Janz, and E.R. Chapman Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons Mol Biol Cell 19 2008 5226 5237
29. M. Dong, W.H. Tepp, H. Liu, E.A. Johnson, and E.R. Chapman Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons J Cell Biol 179 2007 1511 1522
30. D. Dressler, and F. Adib Saberi Botulinum toxin: mechanisms of action Eur Neurol 53 2005 3 9 (Pubitemid 40522824)
31. D. Dressler, and R. Benecke Pharmacology of therapeutic botulinum toxin preparations Disabil Rehabil 29 2007 761 768
32. D. Dressler, and H. Bigalke Antibody-induced failure of botulinum toxin type B therapy in de novo patients Eur Neurol 52 2004 132 135 (Pubitemid 39551719)
33. D. Dressler, and M. Hallett Immunological aspects of Botox®, Dysport® and Myobloc®/NeuroBloc® Eur J Neurol 13 Suppl 1 2006 11 15
34. D. Dressler Clinical features of antibody-induced complete secondary failure of botulinum toxin therapy Eur Neurol 48 2002 26 29 (Pubitemid 34899274)
35. K.H. Eisele, and H.V. Taylor Dissociation of the 900 kDa neurotoxin complex from Clostridium botulinum under physiological conditions Toxicon 51 Suppl. 1 2008 10
36. F.J. Erbguth From poison to remedy: the chequered history of botulinum toxin J Neural Transm 115 2008 559 565
37. E. Fernandez-Salas, L.E. Steward, H. Ho, P.E. Garay, S.W. Sun, and M.A. Gilmore Plasma membrane localization signals in the light chain of botulinum neurotoxin Proc Natl Acad Sci U S A. 101 2004 3208 3213 (Pubitemid 38327759)
38. G.M. Filippi, P. Errico, R. Santarelli, B. Bagolini, and E. Manni Botulinum A toxin effects on rat jaw muscle spindles Acta Otolaryngol 113 1993 400 404 (Pubitemid 23124001)
39. A. Fischer, and M. Montal Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes Proc Natl Acad Sci U S A. 104 2007 10447 10452 (Pubitemid 47185685)
40. P.G. Foran, N. Mohammed, G.O. Lisk, S. Nagwaney, G.W. Lawrence, and E. Johnson Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons J Biol Chem. 278 2003 1363 1371 (Pubitemid 36790822)
41. G. Franchi Time course of motor cortex reorganization following botulinum toxin injection into the vibrissal pad of the adult rat Eur J Neurosci 16 2002 1333 1348 (Pubitemid 35340857)
42. G. Franchi, and C. Veronesi Time course for the reappearance of vibrissal motor representation following botulinum toxin injection into the vibrissal pad of the adult rat Eur J Neurosci 20 2004 1873 1884 (Pubitemid 39471581)
43. G. Franciosa, A. Maugliani, F. Floridi, and P. Aureli A novel type A2 neurotoxin gene cluster in Clostridium botulinum strain Mascarpone FEMS Microbiol Lett. 261 2006 88 94 (Pubitemid 43999706)
44. D.M. Gill Bacterial toxins: a table of lethal amounts Microbiol Rev 46 1982 86 94
45. H. Göschel, K. Wohlfarth, J. Frevert, R. Dengler, and H. Bigalke Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies - therapeutic consequences Exp Neurol 147 1997 96 102 (Pubitemid 27402446)
46. J.M. Gracies Physiological effects of botulinum toxin in spasticity Mov Disord 19 Suppl 8 2004 S120 S128
47. J.M. Gracies, M. Lugassy, D.J. Weisz, M. Vecchio, S. Flanagan, and D.M. Simpson Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study Arch Phys Med Rehabil 90 2009 9-16.e2
48. E. Habermann, and U. Weller Structure-activity relationships of tetanus in comparison to botulinum toxins G. Nistico B. Bizzini B. Bytchenko R. Triau, editors. Eighth International Conference on Tetanus: Rome-Milan 1989 Pythagora Press 43 50
49. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch Pharmacol 281 1974 47 56
50. K. Hasegawa, T. Watanabe, T. Suzuki, A. Yamano, T. Oikawa, and Y. Sato A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms J Biol Chem 282 2007 24777 24783 (Pubitemid 47347510)
51. J.B. Holds, K. Alderson, S.G. Fogg, and R.L. Anderson Motor nerve sprouting in human orbicularis muscle after botulinum A injection Invest Ophthalmol Vis Sci. 31 1990 964 967 (Pubitemid 20186110)
52. A.K. Horn, J.D. Porter, and C. Evinger Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics Exp. Brain Res 96 1993 39 53 (Pubitemid 23332177)
53. J.M. Hughes, J.R. Blumenthal, M.H. Merson, G.L. Lombard, V.R. Dowell Jr., and E.J. Gangarosa Clinical features of types A and B food-borne botulism Ann Intern Med. 95 1981 442 445
54. K. Inoue, Y. Fujinaga, T. Watanabe, T. Ohyama, K. Takeshi, and K. Moriishi Molecular composition of Clostridium botulinum type A progenitor toxins Infect Immun. 64 1996 1589 1594 (Pubitemid 26129820)
55. R. Jin, A. Rummel, T. Binz, and A.T. Brunger Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity Nature 444 2006 1092 1095 (Pubitemid 46018531)
56. Y. Jin, Y. Takegahara, Y. Sugawara, T. Matsumura, and Y. Fujinaga Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C Microbiology. 155 2009 35 45
57. W.H. Jost, J. Blümel, and S. Grafe Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia Drugs. 67 2007 669 683 (Pubitemid 46535642)
58. P. Juzans, J.X. Comella, J. Molgó, L. Faille, and D. Angaut-Petit Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle Neuromuscul Disord. 6 1996 177 185 (Pubitemid 26171260)
59. J. Kerner Vergiftung durch verdorbene Würste Tübinger Blätter für Naturwissenschaften und Arzneykunde 3 1817 1 25
60. M. Kitamura, M. Iwamori, and Y. Nagai Interaction between Clostridium botulinum neurotoxin and gangliosides Biochim Biophys Acta. 628 1980 328 335 (Pubitemid 10119130)
61. G. Kranz, T. Sycha, B. Voller, G.S. Kranz, P. Schnider, and E. Auff Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A Neurology 70 2008 133 136
62. L.K. Koriazova, and M. Montal Translocation of botulinum neurotoxin light chain protease through the heavy chain channel Nat Struct Biol. 10 2003 13 18 (Pubitemid 36034171)
63. D.B. Lacy, W. Tepp, A.C. Cohen, B.R. DasGupta, and R.C. Stevens Crystal structure of botulinum neurotoxin type A and implications for toxicity Nat Struct Biol. 5 1998 898 902 (Pubitemid 28467413)
64. C. Lamanna, H.W. Eklund, and O.E. McElroy Botulinum toxin (type A); including a study of shaking with chloroform as a step in the isolation procedure J Bacteriol. 52 1946 1 13
65. J.C. Lee, K. Yokota, H. Arimitsu, H.J. Hwang, Y. Sakaguchi, and J. Cui Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin Microbiology. 151 2005 3739 3747 (Pubitemid 41632084)
66. M.A. Lietzow, E.T. Gielow, D. Le, J. Zhang, and M.F. Verhagen Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis Protein J 27 2008 420 425
67. E.C. Lim, and R.C. Seet Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion Acta Neurol Scand 117 2008 73 84
68. S. Mahrhold, A. Rummel, H. Bigalke, B. Davletov, and T. Binz The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves FEBS Lett 580 2006 2011 2014
69. T. Matsumura, Y. Jin, Y. Kabumoto, Y. Takegahara, K. Oguma, W.I. Lencer, et al. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption Cell Microbiol 10 2008 355 364
70. F.A. Meunier, G. Schiavo, and J. Molgó Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission J Physiol (Paris). 96 2002 105 113 (Pubitemid 34087038)
71. J. Molgó, J.X. Comella, D. Angaut-Petit, M. Pécot- Dechavassine, N. Tabti, and L. Faille Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions J Physiol (Paris). 84 1990 152 166 (Pubitemid 20327511)
72. C. Montecucco, and J. Molgó Botulinal neurotoxins: revival of an old killer Curr Opin Pharmacol. 5 2005 274 279 (Pubitemid 40674251)
73. L. Morbiato, L. Carli, E.A. Johnson, C. Montecucco, J. Molgó, and O. Rossetto Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C Eur J Neurosci. 25 2007 2697 2704 (Pubitemid 46888844)
74. B. Moreno-Lopez, R.R. de La Cruz, A.M. Pastor, and J.M. Delgado-Garcia Botulinum neurotoxin alters the discharge characteristics of abducens motoneurons in the alert cat J Neurophysiol. 72 1994 2041 2044 (Pubitemid 24325122)
75. T. Nishiki, Y. Kamata, Y. Nemoto, A. Omori, T. Ito, and M. Takahashi Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes J Biol Chem. 269 1994 10498 10503 (Pubitemid 24198248)
76. A. Oeconomou, H. Madersbacher, G. Kiss, T.J. Berger, M. Melekos, and P. Rehder Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature Eur Urol 54 2008 765 775
77. N. Panjwani, O'Keeffe, and A. Pickett Biochemical, functional and potency characteristics of type A botulinum toxin in clinical use Botulinum J 1 2008 153 166
78. A.M. Pastor, B. Moreno-Lopez, R.R. de La Cruz, and J.M. Delgado-Garcia Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations Neuroscience 81 1997 457 478 (Pubitemid 27382000)
79. A. Pickett, R. O'Keeffe, and N. Panjwani The protein load of therapeutic botulinum toxin Eur J Neurol 14 2007 e11
80. A. Pickett, and D. Caird Comparison of type a botulinum toxin products in clinical use J Clin Pharm Ther. 33 2008 327 328 (Pubitemid 351629749)
81. M. Popoff, J.P. Carlier, and B. Poulain Botulisme Maladies infectieuses EMC 2008 Elsevier Masson SAS Paris 8-038-H-50.
82. J.D. Porter, S. Strebeck, and N.F. Capra Botulinum-induced changes in monkey eyelid muscle. Comparison with changes seen in extraocular muscle Arch Ophthalmol 109 1991 396 404
83. B. Poulain, M.R. Popoff, and J. Molgó How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action Botulinum J 1 2008 14 87
84. B. Poulain, L. Tauc, E.A. Maisey, J.D. Wadsworth, P.M. Mohan, and J.O. Dolly Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain Proc Natl Acad Sci U S A. 85 1988 4090 4094 (Pubitemid 18160672)
85. A. Priori, A. Berardelli, B. Mercuri, and M. Manfredi Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles Brain 118 1995 801 807
86. E. Ravichandran, Y. Gong, F.H. Al Saleem, D.M. Ancharski, S.G. Joshi, and L.L. Simpson An initial assessment of the systemic pharmacokinetics of botulinum toxin J Pharmacol Exp Ther. 318 2006 1343 1351 (Pubitemid 44268344)
87. R.L. Rosales, K. Arimura, S. Takenaga, and M. Osame Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection Muscle Nerve. 19 1996 488 496 (Pubitemid 26104299)
88. R.L. Rosales, H. Bigalke, and D. Dressler Pharmacology of botulinum toxin: differences between type A preparations Eur J Neurol. 13 Suppl 1 2006 2 10
89. O. Rossetto, G. Schiavo, C. Montecucco, B. Poulain, F. Deloye, L. Lozzi, et al. SNARE motif and neurotoxins Nature 372 1994 415 416
90. A. Rummel, T. Karnath, T. Henke, H. Bigalke, and T. Binz Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G J Biol Chem. 279 2004 30865 30870 (Pubitemid 38938022)
91. A. Rummel, T. Eichner, T. Weil, T. Karnath, A. Gutcaits, and S. Mahrhold Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept Proc Natl Acad Sci U S A. 104 2007 359 364 (Pubitemid 46068036)
92. T. Sakaba, A. Stein, R. Jahn, and E. Neher Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage Science. 309 2005 491 494 (Pubitemid 40994692)
93. M. Santini, S. Fabri, P. Sagnelli, M. Manfredi, and A. Francia Botulism: a case associated with pyramidal signs Eur J Neurol. 6 1999 91 93 (Pubitemid 29092365)
94. E.J. Schantz, and E.A. Johnson Properties and use of botulinum toxin and other microbial neurotoxins in medicine Microbiol Rev. 56 1992 80 99
95. G. Schiavo, F. Benfenati, B. Poulain, O. Rossetto, P. Polverino de Laureto, B.R. DasGupta, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin Nature. 359 1992 832 835
96. H. Schulte-Baukloh, H. Bigalke, K. Miller, G. Heine, D. Pape, and J. Lehmann Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure Int J Urol. 15 2008 407 415 (Pubitemid 351623889)
97. A.B. Scott, and D. Suzuki Systemic toxicity of botulinum toxin by intramuscular injection in the monkey Mov Disord 3 1988 333 335
98. L.L. Simpson Identification of the major steps in botulinum toxin action Annu Rev Pharmacol Toxicol. 44 2004 167 193 (Pubitemid 38263838)
99. T.J. Smith, J. Lou, I.N. Geren, C.M. Forsyth, R. Tsai, and S.L. Laporte Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization Infect Immun. 73 2005 5450 5457 (Pubitemid 41192979)
100. T.J. Smith, K.K. Hill, B.T. Foley, J.C. Detter, A.C. Munk, D.C. Bruce, et al. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids PLoS ONE 2 2007 e1271
101. L.A. Smith Bacterial protein toxins as biological weapons J. Alouf M.R. Popoff, editors. The comprehensive sourcebook of bacterial protein toxins 3rd ed. 2006 Academic Press San Diego 1019 1030
102. S. Sugii, I. Ohishi, and G. Sakaguchi Intestinal absorption of botulinum toxins of different molecular sizes in rats Infect Immun. 17 1977 491 496 (Pubitemid 8184173)
103. S. Sugii, and G. Sakaguchi Molecular construction of Clostridium botulinum type A toxins Infect Immun. 12 1975 1262 1270
104. S. Takamori, M. Holt, K. Stenius, E.A. Lemke, M. Gronborg, and D. Riedel Molecular anatomy of a trafficking organelle Cell. 127 2006 831 846 (Pubitemid 44716256)
105. D.D. Tang-Liu, K.R. Aoki, J.O. Dolly, A. de Paiva, T.L. Houchen, L.F. Chasseaud, et al. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution Toxicon. 42 2003 461 469
106. A. Teymoortash, F. Sommer, R. Mandic, S. Schulz, M. Bette, and G. Aumüller Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells Br J Pharmacol. 152 2007 161 167 (Pubitemid 47339910)
107. S. Thesleff, J. Molgó, and S. Tagerud Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins J Physiol (Paris). 84 1990 167 173 (Pubitemid 20327512)
108. C. Trompetto, A. Curra, A. Buccolieri, A. Suppa, G. Abbruzzese, and A. Berardelli Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex Mov Disord. 21 2006 777 782 (Pubitemid 44028296)
109. H.R. Tyler Botulinus toxin: effect on the central nervous system of man Science. 139 1963 847 848
110. I. Ugalde, S.P. Christiansen, and L.K. McLoon Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling Invest Ophthalmol Vis Sci. 46 2005 4114 4120 (Pubitemid 44264612)
111. E.P. van Ermengem Über einen neuen anaeroben Bacillus und seine Beziehung zum Botulismus Z Hyg Infektionskrankh. 26 1897 1 56
112. (English translation: Van Ermengem EP. A new anaerobic bacillus and its relation to botulism. Rev Infect Dis. 1979;1:701-19.).
113. C. Verderio, C. Grumelli, L. Raiteri, S. Coco, S. Paluzzi, and P. Caccin Traffic of botulinum toxins A and E in excitatory and inhibitory neurons Traffic 8 2007 142 153 (Pubitemid 46100001)
114. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection Naunyn Schmiedebergs' Arch Pharmacol. 292 1976 161 165
115. H. Wiegand, and H.H. Wellhöner The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex Naunyn Schmiedebergs' Arch Pharmacol 298 1977 235 238 (Pubitemid 8140643)
116. K. Wohlfarth, M. Schubert, B. Rothe, J. Elek, and R. Dengler Remote F-wave changes after local botulinum toxin application Clin Neurophysiol 112 2001 636 640 (Pubitemid 32245637)
117. K. Wohlfarth, C. Müller, I. Sassin, G. Comes, and S. Grafe Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins Clin Neuropharmacol 30 2007 86 94 (Pubitemid 46581201)
118. K. Wohlfarth, I. Schwandt, F. Wegner, T. Jürgens, G. Gelbrich, A. Wagner, et al. Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study J Neurol 255 2008 1932 1939
119. B.A. Woodruff, P.M. Griffin, L.M. McCroskey, J.F. Smart, R.B. Wainwright, R.G. Bryant, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988 J Infect Dis 166 1992 1281 1286
120. B.C. Yowler, R.D. Kensinger, and C.L. Schengrund Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I J Biol Chem 277 2002 32815 32819
121. L. Zhang, W.J. Lin, S. Li, and K.R. Aoki Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain Gene 315 2003 21 32 (Pubitemid 37214894)